| First Author | Chen TC | Year | 2017 |
| Journal | Sci Signal | Volume | 10 |
| Issue | 489 | PubMed ID | 28743803 |
| Mgi Jnum | J:258551 | Mgi Id | MGI:6142099 |
| Doi | 10.1126/scisignal.aai7905 | Citation | Chen TC, et al. (2017) The glucocorticoid-Angptl4-ceramide axis induces insulin resistance through PP2A and PKCzeta. Sci Signal 10(489) |
| abstractText | Chronic glucocorticoid exposure is associated with the development of insulin resistance. We showed that glucocorticoid-induced insulin resistance was attenuated upon ablation of Angptl4, a glucocorticoid target gene encoding the secreted protein angiopoietin-like 4, which mediates glucocorticoid-induced lipolysis in white adipose tissue. Through metabolomic profiling, we revealed that glucocorticoid treatment increased hepatic ceramide concentrations by inducing enzymes in the ceramide synthetic pathway in an Angptl4-dependent manner. Angptl4 was also required for glucocorticoids to stimulate the activities of the downstream effectors of ceramide, protein phosphatase 2A (PP2A) and protein kinase Czeta (PKCzeta). We further showed that knockdown of PP2A or inhibition of PKCzeta or ceramide synthesis prevented glucocorticoid-induced glucose intolerance in wild-type mice. Moreover, the inhibition of PKCzeta or ceramide synthesis did not further improve glucose tolerance in Angptl4(-/-) mice, suggesting that these molecules were major downstream effectors of Angptl4. Overall, our study demonstrates the key role of Angptl4 in glucocorticoid-augmented hepatic ceramide production that induces whole-body insulin resistance. |
